2023 Regular Session • Maryland Legislature
HB376: Health Insurance - Diagnostic and Supplemental Examinations and Biopsies for Breast Cancer - Cost-Sharing
Legislative Summary
Prohibiting, except under certain circumstances, insurers, nonprofit health service plans, and health maintenance organizations that provide coverage for diagnostic and supplemental breast examinations from imposing a copayment, coinsurance, or deductible requirement for the examination; and requiring the Maryland Health Care Commission to study and report to the Governor and certain committees of the General Assembly by October 1, 2023 on the financial impact of eliminating cost-sharing for diagnostic image-guided biopsies for breast cancer.
Bill History
1/26/2023
First Reading Health and Government Operations
House of Delegates
1/26/2023
Hearing 2/16 at 1:00 p.m.
House of Delegates
2/27/2023
Favorable Report by Health and Government Operations
House of Delegates
2/28/2023
Favorable Adopted Second Reading Passed
House of Delegates
3/2/2023
Third Reading Passed (134-0)
House of Delegates
3/3/2023
Referred Finance
Senate
3/30/2023
Favorable with Amendments Report by Finance
Senate
3/30/2023
Favorable with Amendments {673320/1 Adopted
Senate
3/30/2023
Second Reading Passed with Amendments
Senate
3/31/2023
Third Reading Passed (46-0)
Senate
4/7/2023
House Concurs Senate Amendments
House of Delegates
4/7/2023
Third Reading Passed (136-0)
House of Delegates
4/7/2023
Passed Enrolled
House of Delegates
5/3/2023
Approved by the Governor - Chapter 299
House of Delegates
Amendments
Favorable with Amendments 673320/1 Adopted
Favorable with Amendments 673320/1 Adopted
3/30/2023Adopted
Roll Call Votes
Third Reading Passed
4/7/2023
136
Yea
0
Nay
4
Not Voting
0
Absent
Result: PASSED
Third Reading Passed
3/31/2023
46
Yea
0
Nay
1
Not Voting
0
Absent
Result: PASSED
Third Reading Passed
3/2/2023
134
Yea
0
Nay
3
Not Voting
3
Absent
Result: PASSED
Status Information
Current Status
Passed(5/3/2023)
Chamber
House of Delegates
Sine DiePrior Session
